Merit Medical Systems vs UFP Technologies
MMSI and UFPT side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MMSI and UFPT compare
Merit Medical Systems is the larger company, worth 2.2 times as much as UFP Technologies ($5.2B against $2.3B).
On earnings, UFP Technologies is cheaper: it trades at 32.2× trailing earnings, against 32.5× for Merit Medical Systems.
Merit Medical Systems grew revenue faster over the last twelve months (9.1% versus 7.3% for UFP Technologies).
UFP Technologies keeps more of each dollar of sales as profit, with a net margin of 11.4% compared with 9.9% at Merit Medical Systems.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MMSI | UFPT |
|---|---|---|
| Size and price | ||
| Market cap | $5.2B | $2.3B |
| Share price | $86.35 | $298.54 |
| Change, 1 year | −1.2% | 27.4% |
| Change, 5 years | 30.6% | 331% |
| Beta (5Y) | 0.30 | 1.27 |
| Employees | 7,500 | 4,846 |
| StockData Score | ||
| Total score | 13 | 13 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 3 | 6 (better) |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 32.5× | 32.2× (better) |
| P/S | 3.2× (better) | 3.7× |
| P/B | 3.0× (better) | 5.0× |
| EV/EBITDA | 15.8× (better) | 25.1× |
| P/FCF | 25.4× | – |
| PEG | 1.78 (better) | 1.88 |
| FCF yield | 3.9% | – |
| Fair value | $92.96 | $241.83 |
| Margin of safety | 7.1% (better) | −23.4% |
| Growth | ||
| Revenue growth (TTM) | 9.1% (better) | 7.3% |
| Revenue growth, 5Y average | 9.5% | 27.4% (better) |
| Net income growth (TTM) | 35.2% (better) | 7.7% |
| EPS growth (TTM) | 36.4% (better) | 7.5% |
| EPS growth, 5Y average | – | 37.7% |
| Profitability | ||
| Gross margin | 49.4% (better) | 28.5% |
| Operating margin | 13.5% | 15.3% (better) |
| Net margin | 9.9% | 11.4% (better) |
| FCF margin | 12.6% | – |
| Return on equity | 9.8% | 17.1% (better) |
| Return on invested capital | 8.5% | 14.2% (better) |
| Financial health | ||
| Debt / equity | 0.42 | 0.25 (better) |
| Net debt / EBITDA | 0.68 (better) | 1.12 |
| Interest coverage | 6.7× | 12.4× (better) |
| Current ratio | 4.52 (better) | 3.00 |
| Altman Z-score | 4.26 | 8.84 (better) |
| Piotroski F-score | 7 (better) | 5 |
| Dividends and buybacks | ||
| Buyback yield | −0.43% | – |
| Shareholder yield | −0.43% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 105% | 123% |
| Held by insiders | 2.7% | 4.5% |
| Insider net buying, 12 months | −$2.7M (better) | −$13.6M |
| Short interest, % of float | 6.9% | 12.4% |
Go deeper
- MMSI stock overview
- MMSI income statement
- MMSI valuation and score
- UFPT stock overview
- UFPT income statement
- UFPT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.